期刊文献+

舒洛地特对糖尿病患者眼底血流及氧化应激因子水平的影响 被引量:4

Effect of sulodexide on the level of stress factors in patients with diabetic fundus blood flow and oxidation
原文传递
导出
摘要 目的探讨舒洛地特在糖尿病患者中运用对患者眼底血流及氧化应激水平的影响。方法 2016年11月-2017年11月在本院治疗的糖尿病视网膜病变患者120例作为研究对象,按照数字表法分为观察组和对照组各60例,对照组糖尿病视网膜病变的常规治疗,观察组患者在对照组患者的基础上联合舒洛地特治疗,对比2组患者眼底血流及血清中氧化应激因子水平。结果治疗后2组患者MDA、AOPP均较前下降,且观察组低于对照组患者;治疗后2组患者抗氧化物GSH-PX、SOD较前明显上升,治疗后观察组患者PSV、EDV、PI均明显优于对照组患者,观察组患者治疗有效、好转人数均高于对照组患者。结论舒洛地特有助于降低机体氧化应激水平、改善眼底血流。 Objective To investigate the effect of sulodexide on the fundus blood flow and oxidative stress in diabetic patients.Methods 120 cases of diabetic retinopathy treated in our hospital from November 2016 to November 2017 were studied. The subjects were divided into the observation group and the control group,with 60 cases in each group. The control group was treated with the routine treatment of diabetic retinopathy. The patients in the observation group were combined with sulodexide on the basis of the treatment group. The fundus blood flow and serum levels of oxidative stress in two groups were compared.Results After treatment,MDA and AOPP decreased in the two groups,and the observation group was lower than the control group. After treatment,the antioxidant GSH-PX and SOD increased significantly in the two groups. After treatment,PSV,EDV and PI in the observation group were significantly higher than those in the control group. The number of effective and improved patients in the observation group was higher than that in the control group. Conclusion Sulodexide helps to reduce oxidative stress and improve the eye ground blood flow.
作者 黄丰 吴春美 沈宏伟 HUANG Feng;WU Chun-mei;SHEN Hong-wei(Pharmacy, Lishui People's Hospital, Lishui, Zhejiang 323000, China)
出处 《中国卫生检验杂志》 CAS 2019年第14期1751-1753,共3页 Chinese Journal of Health Laboratory Technology
关键词 舒洛地特 糖尿病 眼底血流 氧化应激 Sulodexide Diabetes mellitus Fundus blood flow Oxidative stress
  • 相关文献

参考文献15

二级参考文献145

  • 1金立,赵文杰,车立群,张伟,吴迪.高压氧治疗2型糖尿病单纯型视网膜病变的价值[J].中国老年学杂志,2014,34(10):2645-2647. 被引量:9
  • 2王伟伟,邹海东,朱剑锋,吴美芳.上海市北新泾街道社区糖尿病眼病3年防治调查[J].中国临床康复,2006,10(44):7-10. 被引量:16
  • 3Diabetic Retinopathy Clinical Research Network. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. JAMA Ophthalmol 2013 ; 131 ( 3 ) : 283 -293.
  • 4Simunovic MP, Maberley DA. Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: A Systemalic Review and Meta-Analysis. Retina 2015 ;35 ( 10 ) : 1931 - 1942.
  • 5Romero-Aroca P. Is laser photocoagulation treatment currently useful in diabetic macular edema? Med Hypothesis Discov Innov Ophthalmol 2015 ;4 (1): 5-8.
  • 6Tripathy K, Sharma YR, Karthikeya R, et al. Recent advances in management of diabetic maeular edema. Curr Diabetes Rev 2015 ; 11 ( 2 ) : 79-97.
  • 7Ferraz DA, Vasquez LM, Preti RC, et al. A randomized controlled trial of panretinal photoeoagulation with and without intravitreal ranibizumab in treatment- naive eyes with non- high- risk proliferative diabetie retinopathy. Retina 2015 ;35 (2) :280-287.
  • 8Lu LC, Zhou W, Li ZH, et al. Effects of arctiin on streptozotocin - induced diabetic retinopathy in Sprague - Dawley rats [ J ]. 'Planta Med, 2012,78 : 1317 - 1323.
  • 9Kashihara N,Haruna Y, Kondeti V K, et al. Oxidative stress in diabetic nephropathy [ J]. Curr Med Chem, 2010,17 ( 34 ) :4256-4269.
  • 10Sedeek M, Nasrallah R, Touyz R M, et al. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe[ J] Am Soc Nephrol,2013,24(10) :1512-1520.

共引文献381

同被引文献69

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部